The official distributor of TEOXANE Laboratories for Croatia and Slovenia is Pontus Pharma

jovana
18/03/2026

We are proud to announce that Pontus Pharma has become the official distributor of TEOXANE Laboratories for the markets of Croatia and Slovenia.

This partnership represents a highly important strategic step in our continued development, as it enables us to expand our aesthetic portfolio with one of the most globally recognized and high-quality brands in the field of hyaluronic acid fillers and skin quality solutions.

TEOXANE Laboratories is a Swiss company globally known for its innovative RHA® (Resilient Hyaluronic Acid) technology, developed to preserve the natural dynamics of the face and achieve natural, flexible, and long-lasting aesthetic results. Today, the brand is considered one of the leaders in the field of hyaluronic acid fillers, with a clear focus on natural appearance and high treatment quality.

In addition to dermal fillers, Teoxane also develops a wide range of dermocosmetic solutions, offering a comprehensive approach to skin care—from professional aesthetic treatments to daily at-home care. This integrated “in-office + at-home” skincare approach further strengthens the concept of skin quality improvement and long-term maintenance of aesthetic results.

As part of the launch, at the AMICO Congress in Opatija we also presented babyGLOW™, a new Teoxane technique developed to improve skin quality and achieve an immediate “glow” effect. The presentation generated strong interest among professionals and confirmed the growing trend of bioregenerative and skin quality treatments in aesthetic medicine.

The inclusion of the Teoxane portfolio in our offering represents a significant strengthening of the direction in which our aesthetic medicine business unit is developing—towards scientifically grounded, high-quality, and clinically relevant solutions that meet the increasingly sophisticated demands of the market and professionals.

With this step, we further confirm our long-term strategy of building a premium aesthetic portfolio and strengthening our position as one of the key partners for innovation in aesthetic medicine in the region.